The 27 references in paper V. Gaynitdinova V., L. Sharafutdinova A., S. Avdeev N., R. Gubaydullina Ya., В. Гайнитдинова В., С. Авдеев Н., Л. Шарафутдинова А., Р. Губайдуллина Я. (2016) “Диагностическая и прогностическая ценность N-концевого предшественника натрийуретического пептида C-типа у больных хронической обструктивной болезнью легких с легочной гипертензией // Diagnostic and prognostic values of N-terminal pro-C type natriuretic peptide in patients with COPD and pulmonary hypertension” / spz:neicon:pulmonology:y:2015:i:6:p:693-697

1
Weitzenblum E., Hirth C., Ducolone A. et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981; 36: 752–758.
(check this in PDF content)
2
Chaouat A., Bugnet A.-S., Kadaoui N. et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189–194.
(check this in PDF content)
3
Andersen K.H., Iversen M., Kjaergaard J. et al. Prevalence, predictors and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. Heart Lung Transplant.2012; 31: 373–380.
(check this in PDF content)
4
Burrows B. Arterial oxygenation and pulmonary hemodynamics in patients with chronic airways obstruction. Am. Rev. Respir. Dis.1974; 110: 64–70.
(check this in PDF content)
5
Wright J.L. Relationship of pulmonary arterial pressure and airflow obstruction to emphysema.J. Appl. Physiol. 1993; 74: 1320–1324.
(check this in PDF content)
6
Santos S., Peinado V.I., Ramirez J. et al. Characterization of pulmonary vascular remodeling in smokers and patients with mild COPD.Eur. Respir. J. 2002; 19: 632–638.
(check this in PDF content)
7
Hale K.A, Ewing S.L., Gosnell B.A. et al. Lung disease in longterm cigarette smokers with and without chronic air-flow obstruction.Am. Rev. Respir. Dis.1984; 130: 716–721.
(check this in PDF content)
8
Peinado V.I., Barbera J.A., Abate P. et al. Infl ammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.1999; 159: 1605–1611.
(check this in PDF content)
9
Dinh-Xuan A.T., Higenbottam T.W., Clelland C.A. et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease.N. Engl. J. Med. 1991; 324: 1539–1547.
(check this in PDF content)
10
Peinado V.I., Barbera J.A., Ramirez J. et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am. J. Physiol.1998; 274: 908–913.
(check this in PDF content)
11
Santos S., Peinado V.I., Ramirez J. et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.Am. J. Respir. Crit. Care Med.2003; 167: 1250–1256.
(check this in PDF content)
12
Sellitti D.F. Regulation of C-type natriuretic peptide expression. Peptides. 2011; 32: 1964–1971.
(check this in PDF content)
13
Cazzola M., MacNee W., Martinez F.J. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur. Respir. J.2008; 31: 416–469.
(check this in PDF content)
14
Seeger W., Adir Y., Barber? J.A. et al. Pulmonary hypertension in chronic lung diseases. J. Am. Coll. Cardiol.2013; 62 (25, Suppl. D): 110–116.
(check this in PDF content)
15
Quanjer Ph.H., Tammelling G., Gotes J.E. et al. Lung volumes and forced ventilator flows. Eur. Respir. J. 1993; 6 (Suppl. 16): 5–40.
(check this in PDF content)
16
Chaouat A., Naeije R., Weitzenblum E. Pulmonary hypertensionin COPD.Eur. Respir. J.2008; 32: 1371–1385.
(check this in PDF content)
17
Scotland R.S., Ahluwalia A., Hobbs A.J. C-type natriuretic peptide in vascular physiology and disease.Pharmacol. Ther. 2005; 105: 85–93.
(check this in PDF content)
18
Almeida F.M., Suzuki M., Scarborough R.M. et al. Clearance function of type C receptors of atrial natriuretic factor in rats. Am. J. Physiol. 1989; 256: 469–475.
(check this in PDF content)
19
Vlachopoulos C., Ioakeimidis N., Terentes-Printzios D. et al. Amino-terminal pro-C-type natriuretic peptide is associated with arterial stiffness, endothelial function and early atherosclerosis. Atherosclerosis. 2010; 211: 649–655
(check this in PDF content)
20
Soeki T., Kishimoto I., Okumura H. et al. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.J. Am. Coll. Cardiol.2005; 5: 608–616.
(check this in PDF content)
21
Suga S., Nakao K., Itoh H. et al. Endothelial production of Ctype natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of «vascular natriuretic peptide system». J. Clin. Invest.1992; 90: 1145–1149.
(check this in PDF content)
22
Naruko T., Itoh A., Haze K. et al. C-type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention. Atherosclerosis. 2005;181: 241–250.
(check this in PDF content)
23
Peltonen T.O., Taskinen P., Soini Y. et al. Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis. Circulation. 2007; 116: 1283–1289.
(check this in PDF content)
24
Christoffersen C., Bartels E.D., Nielsen L.B. Heart specific upregulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice.Eur. J. Clin. Invest.2006; 36: 69–75.
(check this in PDF content)
25
Suga S., Itoh H., Komatsu Y. et al. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine / paracrine regulator from endothelial cells. Endocrinology. 1993; 133: 3038–3041.
(check this in PDF content)
26
Cargill R.I., Barr C.S., Coutie W.J. et al. C-type natriuretic peptide levels in cor pulmonale and in congestive heart failure. Thorax. 1994; 49: 1247–1249.
(check this in PDF content)
27
Неклюдова Г.В., Авдеев С.Н., Баймаканова Г.Е. Хроническая обструктивная болезнь легких и легочная гипертензия: мозговой натрийуретический пептид как маркер легочной гипертензии. Пульмонология. 2013; 3: 31–35. / Neklyudova G.V., Avdeev S.N., Baymakanova G.E. Chronic
(check this in PDF content)